PPARA and metabolic dysfunction-associated steatotic liver disease: The United States (US) National Institutes of Health’s Clinical Trials Information website (https://clinicaltrials.gov/; accessed on 14 August 2023) contained the details of 42 clinical trials for NAFLD/NASH using nine PPAR agonists that had been so far completed or terminated (Table 1).